Authors:
Kiran Pulidindi, Kunal Ahuja
Download free PDF
Biofortification Market Size & Share 2026-2035
Report ID: GMI10771
|
Published Date: August 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Download Free PDF
Explore Our Licensing Options:
Download Free PDF
Biofortification Market
Get a free sample of this report
Get a free sample of this report Biofortification Market
Is your requirement urgent? Please give us your business email
for a speedy delivery!
Biofortification Market Size
The biofortification market was valued at USD 164.5 million in 2025 and will grow from USD 176.7 million in 2026 to USD 338.1 million by 2035, at a 7.5% CAGR over 2026-2035, according to the latest report published by Global Market Insights Inc.
Biofortification Market Key Takeaways
Market Leader: HarvestPlus led with over 18.3% market share in 2025.
Leading Players: Top 5 players in this market include HarvestPlus, BASF SE, CIMMYT, IITA, Nestlé S.A., which collectively held a market share of 52.7% in 2025.
The market covers commercial development, distribution, and institutional or commercial expenditure for biofortified crop varieties, planting material, and agronomic nutrient-delivery products. It includes conventional plant breeding, genetic modification, and agronomic biofortification, while excluding post-harvest food fortification, standalone dietary supplements, and conventional seed markets. Historic revenue expanded through 2022-2025 as HarvestPlus delivery programs, CGIAR germplasm releases, and national nutrition initiatives broadened access to nutrient-enhanced staples. [1]CGIAR, cgiar.org
The market’s economics turn on whether a validated crop variety can move through approval, multiplication, and farmer distribution before a public-health program loses momentum. Crop-specific multi-location trials, regulatory or program-authority approval, and seed-system development differentiate biofortification from conventional food fortification. Those requirements constrain the supply of qualified varieties and favor institutions with proven germplasm portfolios and multiplication networks. The forecast uses a bottom-up assessment of program-linked seed activity, commercial agronomic inputs, and ingredient demand, triangulated against regional adoption and technology pathways.
GMI Analyst View
Growth through 2035 will depend more on seed-system execution and government nutrition-program integration than on breeding technology alone. Institutions that combine certified germplasm with farmer-accessible supply networks will capture a disproportionate share of expansion in Asia Pacific and sub-Saharan Africa. Agronomic biofortification adds a parallel demand channel because micronutrient fertilizer programs can react to deficiency data faster than breeding pipelines.
Key Drivers
More than 2 billion people experience micronutrient deficiencies globally, creating a persistent need for interventions that work through staple-food systems. [2]World Health Organization, who.int Iron deficiency affects roughly 1.6 billion people, while zinc and vitamin A deficiency remain prevalent across staple-dependent populations in low- and middle-income countries. Biofortified crops address this hidden-hunger burden at production rather than requiring continuous supplementation. That delivery logic supports integration into food-security strategies across Asia Pacific and Africa.
CGIAR and HarvestPlus have sustained crop-development and delivery investment across national programs. Government distribution systems in India, Bangladesh, Nigeria, and Rwanda are creating more stable institutional demand than spot commercial procurement. Donor capital also compresses development timelines: CIMMYT received USD 15 million from the Gates Foundation in November 2025 to expand provitamin A maize breeding in sub-Saharan Africa. Program-backed demand gives certified seed producers clearer volume signals and lowers route-to-market uncertainty.
Marker-assisted selection, genomic prediction, and gene-editing tools reduce the time needed to identify suitable nutrient traits alongside yield and adaptation. IITA uses DArTseq and KASP markers in its cassava pipeline, while IRRI released the zinc rice variety Spoorthi in India in June 2025. The gain is operational as much as scientific: faster selection brings seed multiplication forward and reduces the lag between documented deficiency and farmer access. CGIAR network countries will see the earliest benefit because testing and delivery infrastructure already exists.
Key Restraints
Limited awareness among farming and consumer communities can constrain uptake even when certified varieties are available. Color, flavor, texture, and confidence in nutritional claims affect adoption, particularly for provitamin A crops and genetically modified varieties. CIP’s delivery programs pair varietal work with nutrition education and local dissemination, reflecting the commercial importance of extension. [3]International Potato Center, cipotato.org This raises program costs because adoption cannot be treated as an automatic result of seed availability.
GM biofortified crops face fragmented approval systems that extend testing and commercialization timelines. Golden Rice approval and deployment history shows how technical validation, national authorization, and legal challenges can shape market access. Multi-jurisdiction certification favors larger developers with regulatory affairs capacity and makes conventional breeding the lower-risk path in many markets.
Weak formal seed systems impede farmer-level access in sub-Saharan Africa, South Asia, and Latin America. Limited certified multiplication, fragmented distribution, and informal seed exchange reduce traceability and weaken the commercial market for improved varieties. ICRISAT’s Dhanashakti pearl millet program shows that cultivar release requires linked government, seed, and distribution activity to reach scale. Public-private seed partnerships are therefore a prerequisite for growth, although they lengthen program payback periods.
GMI Analyst View
The driver-restraint balance supports growth through 2035, but adoption will diverge by crop and geography. Conventional varieties will retain broad deployment because they avoid the approval risk associated with GM crops. Agronomic biofortification offers an immediately deployable alternative where breeding and regulatory timelines are longest, favoring suppliers that pair germplasm or inputs with seed-system and government-program partnerships.
Biofortification Market Segment Analysis
By Crop Type
Cereals and grains generated USD 59.9 million in 2025, the largest crop-type segment, because wheat, rice, and maize carry nutrition interventions through widely consumed staples. CIMMYT has advanced zinc wheat, provitamin A maize, and quality protein maize, including 24 provitamin A maize products available for licensing. [4]International Maize and Wheat Improvement Center, cimmyt.org Legumes and pulses are gaining traction through iron-bean delivery in Rwanda, Uganda, and the Democratic Republic of the Congo. Roots and tubers will grow fastest as CIP’s orange-fleshed sweet potato work and IITA’s provitamin A cassava releases expand.
Zinc accounted for USD 56.7 million in 2025, led by zinc wheat and rice programs across Asia and Africa. Iron is the next largest nutrient route, with beans and pearl millet serving as key delivery crops for anemia-focused programs. Vitamins will grow fastest as provitamin A maize, cassava, and sweet potato programs extend into national nutrition channels. Quality protein maize shows how protein and amino-acid enhancement can broaden the market beyond micronutrients.
By Technology
Conventional plant breeding generated USD 89.6 million in 2025 and remains dominant because it fits existing release systems and avoids GM-related restrictions. Genetic modification is smaller but growing faster as gene-editing and stacked-trait programs reach approval pathways. IRRI’s high iron and zinc rice and 3-in-1 rice demonstrate the potential for multi-nutrient trait combinations. [5]International Rice Research Institute, irri.org Agronomic biofortification uses zinc and iron nutrient products to raise edible-crop nutrient content and provides the fastest implementation route where qualified varieties are unavailable.
By End Use
The food industry generated USD 74.8 million in 2025, supported by institutional feeding programs and manufacturers sourcing nutrient-enhanced ingredients. Feed applications remain secondary but benefit from quality-protein and mineral-density improvements in staple crops.
Healthcare and nutraceuticals will grow fastest as traceable biofortified inputs gain relevance in therapeutic nutrition and functional-food formulations. Nestlé and BASF are positioned to connect agricultural nutrition attributes with food formulation and ingredient demand.
GMI Analyst View
The mix will shift toward higher-value applications as delivery programs mature. Conventional plant breeding will remain the largest technology route, while genetic modification will add share where approvals support commercialization. By 2030, traceability from certified seed to finished ingredient will separate organizations serving program markets from those capturing functional-food and nutraceutical demand.
Biofortification Market Regional Analysis
North America
North America generated USD 53.4 million in 2025 and will reach USD 111.8 million by 2035; the U.S. accounted for USD 42.7 million in 2025. Demand is supported by research investment, seed technology, and the nutraceutical market’s interest in differentiated crop ingredients. U.S. biotechnology rules create a more open GM commercialization pathway than Europe, while Canada contributes smaller health-food and ingredient demand. Corporate activity by Corteva and nutrition capabilities at BASF reinforce the region’s commercial base.
Europe generated USD 30.3 million in 2025 and will reach USD 64.4 million by 2035, making it the fastest-growing region. Farm to Fork policy emphasizes sustainable food systems and strengthens the case for conventional nutrient-dense crops. [6]European Commission, commission.europa.eu Consumer preference for non-GMO products supports conventional breeding and agronomic approaches, but the region’s restrictive GMO rules limit GM variety uptake. Europe’s opportunity is a premium ingredient market rather than broad public staple-food distribution.
Asia Pacific
Asia Pacific led the market at USD 61.6 million in 2025 and will reach USD 128.7 million by 2035. India, Bangladesh, and the Philippines combine large staple-food demand with established public nutrition channels. IRRI’s 2025 release of Spoorthi zinc rice and HarvestPlus’s iron-rice work in Bangladesh extend the region’s rice portfolio. Population scale and program depth will sustain regional leadership, although state-level delivery and farmer preferences require localized varieties.
Latin America
Latin America generated USD 10.6 million in 2025 and will reach USD 19.0 million by 2035. Brazil and Mexico anchor regional activity through agriculture research and rural nutrition programs, while CIMMYT’s maize work and the Alliance of Bioversity International and CIAT’s iron-bean expertise support crop pipelines. Regional growth remains program-led, and uneven seed investment limits the conversion of breeding advances into commercial distribution.
Middle East & Africa
Middle East and Africa generated USD 8.6 million in 2025 and will reach USD 14.2 million by 2035. Demand is concentrated in sub-Saharan Africa, where provitamin A cassava, orange-fleshed sweet potato, iron beans, and biofortified maize address staple-dependent diets. Africa Improved Foods demonstrates how local procurement and food manufacturing can complement crop-level interventions. [7]Africa Improved Foods, africaimprovedfoods.com The region’s upside depends on donor-backed procurement transitioning into durable domestic seed and food-system capacity.
GMI Analyst View
Asia Pacific will retain the largest revenue base through 2035 because population scale aligns with established nutrition programs. Europe will grow faster in percentage terms as non-GM biofortification aligns with its policy and ingredient-market profile. Donor capital in sub-Saharan Africa and South Asia can compress development timelines, but seed-system gaps will remain the decisive constraint on turning commitments into revenue.
Biofortification Market Share & Competitive Landscape
HarvestPlus led the market with an estimated 18.3% share in 2025. HarvestPlus, BASF SE, CIMMYT, IITA, and Nestlé S.A. collectively held 52.7%, reflecting moderate concentration across program implementers, research institutions, nutrition companies, and input suppliers. CGIAR centers differentiate through germplasm, release rates, and national-program partnerships; private companies compete through ingredient supply chains, biotechnology, and crop-input channels. Pricing follows program economics more than standard commercial seed pricing: qualified seed earns a premium where public distribution supports adoption, while agronomic products trade closer to micronutrient fertilizer economics. Corteva’s May 2024 acquisition of Arcadia Biosciences’ resistant-starch durum wheat trait illustrates continuing corporate interest in nutrition-related crop intellectual property. [8]BusinessWire, businesswire.com
Recent Industry Developments
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →